Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Journal of Breast Cancer|April 7, 2017
Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast CancerJi-Hye Lee, Sang Byung Bae, Mee-Hye Oh, et al.The American Journal of Surgical Pathology|February 13, 2014
Pyloric gland adenoma in Lynch syndromeSeung Eun Lee, So Young Kang, Junhun Cho, et al.Head and Neck Pathology|March 18, 2026
International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR InitiativeBeth M Beadle, Nazim Benzerdjeb, Junhun Cho, et al.Blood Advances|September 17, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsJiwon Koh, Insoon Jang, Seungchan Mun, et al.Cancer Research and Treatment|September 4, 2019
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II TrialSeok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, et al.Head & Neck|January 7, 2020
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature reviewTaebum Lee, Junhun Cho, Chung-Hwan Baek, et al.Blood Advances|December 9, 2025
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphomaSang Eun Yoon, Woorim Kang, Junhun Cho, et al.Blood|August 9, 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.International Journal of Cancer|February 26, 2019
Bridging genomics and phenomics of gastric carcinomaJunhun Cho, Soomin Ahn, Dae-Soon Son, et al.Pageof 12